Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tatsu Shimoyama

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 22, 2009
[Cetuximab (Erbitux)]Tatsu Shimoyama
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 29, 2023
[Current and future perspectives on CAR-T cell therapy to adult malignant lymphoma]Tatsu Shimoyama
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 20, 2009
[Bevacizumab (Avastin)]Tatsu Shimoyama
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 10, 2023
[CAR-T therapy for malignant lymphoma]Tatsu Shimoyama
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 18, 2007
[Genomic and post-genomic approaches to cancer biomarker discovery - microarray standards at last]Tatsu Shimoyama, Tsuneo Sasaki
Annals of Hematology|February 11, 2018
Geriatric nutritional risk index as a prognostic factor in patients with diffuse large B cell lymphomaYusuke Kanemasa, Tatsu Shimoyama, Yuki Sasaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 9, 2020
[Clinical Efficacy of mFOLFOX6 for Advanced Gastric Cancer]Chikako Funasaka, Yusuke Kanemasa, Tatsu Shimoyama, et al.
International Journal of Cancer|March 12, 2005
Establishment of a human non-small cell lung cancer cell line resistant to gefitinibFumiaki Koizumi, Tatsu Shimoyama, Fumiko Taguchi, et al.
Case Reports in Oncology|October 2, 2019
Modified FOLFOX-6 Plus Bevacizumab Chemotherapy for Metastatic Colorectal Cancer in Patients Receiving Hemodialysis: A Report of Three Cases and Review of the LiteratureChikako Funasaka, Yusuke Kanemasa, Tatsu Shimoyama, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 24, 2020
[Efficacy of Amrubicin Monotherapy for Patients with Extrapulmonary Neuroendocrine Carcinomas Refractory to Platinum-Based Chemotherapy]Chikako Funasaka, Yusuke Kanemasa, Akihiko Kageyama, et al.
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 22, 2009
[Cetuximab (Erbitux)]Tatsu Shimoyama
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 29, 2023
[Current and future perspectives on CAR-T cell therapy to adult malignant lymphoma]Tatsu Shimoyama
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 20, 2009
[Bevacizumab (Avastin)]Tatsu Shimoyama
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 10, 2023
[CAR-T therapy for malignant lymphoma]Tatsu Shimoyama
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 18, 2007
[Genomic and post-genomic approaches to cancer biomarker discovery - microarray standards at last]Tatsu Shimoyama, Tsuneo Sasaki
Annals of Hematology|February 11, 2018
Geriatric nutritional risk index as a prognostic factor in patients with diffuse large B cell lymphomaYusuke Kanemasa, Tatsu Shimoyama, Yuki Sasaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 9, 2020
[Clinical Efficacy of mFOLFOX6 for Advanced Gastric Cancer]Chikako Funasaka, Yusuke Kanemasa, Tatsu Shimoyama, et al.
International Journal of Cancer|March 12, 2005
Establishment of a human non-small cell lung cancer cell line resistant to gefitinibFumiaki Koizumi, Tatsu Shimoyama, Fumiko Taguchi, et al.
Case Reports in Oncology|October 2, 2019
Modified FOLFOX-6 Plus Bevacizumab Chemotherapy for Metastatic Colorectal Cancer in Patients Receiving Hemodialysis: A Report of Three Cases and Review of the LiteratureChikako Funasaka, Yusuke Kanemasa, Tatsu Shimoyama, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 24, 2020
[Efficacy of Amrubicin Monotherapy for Patients with Extrapulmonary Neuroendocrine Carcinomas Refractory to Platinum-Based Chemotherapy]Chikako Funasaka, Yusuke Kanemasa, Akihiko Kageyama, et al.
Pageof 8